Showing results (241-250 of 273) with videos related to

Sort By:
Pageof 28
Journal of the American College of Cardiology|September 11, 2010
Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphateLaurent Bonello, Udaya S Tantry, Rossella Marcucci, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Coronary Stenting in High Bleeding Risk Patients With Small Coronary Arteries Followed by One-Month Dual Antiplatelet Therapy: Onyx ONE ClearRaúl Moreno, David E Kandzari, Ajay J Kirtane, et al.
American Heart Journal|January 25, 2008
A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery diseaseGiuseppe G L Biondi-Zoccai, Marzia Lotrionte, Claudio Moretti, et al.
European Heart Journal|April 22, 2015
Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary interventionDániel Aradi, Ajay Kirtane, Laurent Bonello, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 1, 2020
Optical coherence tomography-guided coronary stent implantation compared to angiography: a multicentre randomised trial in PCI - design and rationale of ILUMIEN IV: OPTIMAL PCIZiad Ali, Ulf Landmesser, Keyvan Karimi Galougahi, et al.
Journal of the American College of Cardiology|October 1, 2013
Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleedingUdaya S Tantry, Laurent Bonello, Daniel Aradi, et al.
Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Patients With Diabetes at High Bleeding Risk With 1-Month Dual Antiplatelet Therapy: Onyx ONE Clear ResultsElvin Kedhi, Stephan Windecker, Azeem Latib, et al.
Circulation. Cardiovascular Interventions|November 10, 2020
One-Month Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention With Zotarolimus-Eluting Stents in High-Bleeding-Risk PatientsDavid E Kandzari, Ajay J Kirtane, Stephan Windecker, et al.
JAMA|March 17, 2011
Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trialMatthew J Price, Peter B Berger, Paul S Teirstein, et al.
European Heart Journal. Imaging Methods and Practice|July 24, 2024
Artificial intelligence coronary computed tomography, coronary computed tomography angiography using fractional flow reserve, and physician visual interpretation in the per-vessel prediction of abnormal invasive adenosine fractional flow reserveAndrew Chiou, Melody Hermel, Rajbir Sidhu, et al.
Pageof 28